News & Events

13 November, 2018

BrainsWay to Showcase FDA-Cleared Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at DGPPN 2018

Jerusalem, DATE: BrainsWay Ltd. (TASE: BRIN), a global leader in the advanced non-invasive treatment...

10 October, 2018

BrainsWay Announces First Shipments of Deep Transcranial Magnetic Stimulation Helmets for the Treatment of Obsessive-Compulsive Disorder

Twenty sites across the U.S. are the first to receive the BrainsWay Deep transcranial magnetic stimulation...

27 August, 2018

BrainsWay Reports Financial Results for Second Quarter of 2018 and Provides Corporate Update

Second quarter revenues of $3.7 million represent a quarterly record and a 57% increase over second quarter...

19 August, 2018

BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive Compulsive Disorder

BrainsWay’s deep transcranial magnetic stimulation (Deep TMS) system is a best-in-class device designed...

30 May, 2018

BrainsWay Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update

First quarter revenues of $3.6 million represent a quarterly record and a  68% increase over first quarter...

23 May, 2018

Achieve TMS Announces Grand Opening of New Location in Newton, Massachusetts

NEWTON, Mass., May 23, 2018 (GLOBE NEWSWIRE) — Achieve TMS, the largest U.S. provider of BrainsWay’s...

10 January, 2013

BrainsWay Receives FDA Clearance

JERUSALEM, Thursday 10, 2013 BrainsWay® Ltd. (TASE: BRIN)  is proud to announce that the U.S. Food...

12 December, 2017

BrainsWay Raises $8.5 Million From Leading Israeli Investors

Phoenix Group becomes 7% shareholder. financing strengthens BrainsWay’s balance sheet and provides...

20 November, 2017

BrainsWay Reports Record Quarterly Revenues in Third Quarter of 2017

ncreased market demand and new leasing model continue to generate significant sales growth Recently signed...

19 October, 2017

The stock in the spotlight:‎ ‎BrainsWay ‎

Sponsor Editoriial Board “The transition to focusing on the leasing business model helps us continue...

23 August, 2017

BrainsWay Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017

Backlog revenues due to future lease agreements increased 27% to $19 million Quarterly revenues increased...

23 June, 2017

Walter Reed National Military Medical Center Acquires a BrainsWay Deep TMS System to Enhance its Treatment of Depression

Walter Reed National Military Medical Center Acquires a BrainsWay® Deep TMS System to Enhance its Treatment...

12 June, 2017

BrainsWay® Announces Positive Final Results of its Deep-TMS Multicenter Study in Obsessive Compulsive Disorder (OCD) Patients

BrainsWay® Announces Positive Final Results of its Deep-TMS Multicenter Study in Obsessive Compulsive...

6 June, 2017

BrainsWay Reports Strong Momentum in Q1 for 2017

BrainsWay Reports Strong Momentum in Q1 for 2017  Company announces $3.7 million in signed lease commitments...

5 April, 2017

BrainsWay Closes 2016 With 69 Percent Increase in Year-over-Year Revenue Growth

BrainsWay Closes 2016 With 69 Percent Increase in Year-over-Year Revenue Growth  Company reaches $11.5...

5 April, 2017

Yaacov Michlin Leads BrainsWay to its Next Growth Phase and Accelerates the Mental Health Industry

JERUSALEM, (GLOBE NEWSWIRE) — BrainsWay Ltd. (TASE:BRIN), the leader in the development of advanced...

28 March, 2017

A Salisbury Clinic Aims To Treat Depression With New Magnetic Device

SALISBURY, Md. – Over 350 million people worldwide suffer from depression. Community Behavioral...